# Combined Use of Naldebain® ER Injection and Precedex® After VATS

> **NCT06176222** · PHASE4 · UNKNOWN · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Acute Post Operative Pain
- Chronic Post Operative Pain
- Postoperative Complications

## Interventions

- **DRUG:** PRECEDEX INJ★ 2ML
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT06176222
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-12-28
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-03-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06176222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06176222, "Combined Use of Naldebain® ER Injection and Precedex® After VATS". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06176222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*